Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1801 for treating staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 for the treatment of papulopustular rosacea; and BTX 1204A for treating atopic dermatitis. The company was incorporated in 1984 and is based in West Perth, Australia.
Show more...
FAQ
Botanix Pharmaceuticals Limited 今天的股價是多少?▼
BOT.AU 目前價格為 A$0.04 AUD,過去 24 小時上漲了 +0%。在圖表上更密切關注 Botanix Pharmaceuticals Limited 股價表現。
Botanix Pharmaceuticals Limited 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Botanix Pharmaceuticals Limited 的股票以代號 BOT.AU 進行交易。
Botanix Pharmaceuticals Limited 的股價在上漲嗎?▼
BOT.AU 股票較上週下跌 -10.26%,本月下跌 -28.57%,過去一年 Botanix Pharmaceuticals Limited 下跌 -90.14%。
Botanix Pharmaceuticals Limited 的市值是多少?▼
今天 Botanix Pharmaceuticals Limited 的市值為 68.89M
Botanix Pharmaceuticals Limited 下一次財報日期是什麼時候?▼
Botanix Pharmaceuticals Limited 將於 August 28, 2026 公布下一次財報。
Botanix Pharmaceuticals Limited 上一季度的財報如何?▼
BOT.AU 上一季度的財報為每股 -0.02 AUD,預估為 -0.01 AUD,帶來 -69% 的驚喜。下一季度的預估財報為每股 不適用 AUD。
Botanix Pharmaceuticals Limited 去年的營收是多少?▼
Botanix Pharmaceuticals Limited 去年的營收為 11.51MAUD。
Botanix Pharmaceuticals Limited 去年的淨利是多少?▼
BOT.AU 去年的淨收益為 -172.79MAUD。
Botanix Pharmaceuticals Limited 會發放股息嗎?▼
是的,BOT.AU 的股息每 半年一次 發放一次。每股最新股息為 52.5 AUD。截至今日,股息殖利率(FWD)% 為 0%。
Botanix Pharmaceuticals Limited 位於哪個產業?▼
Botanix Pharmaceuticals Limited從事於Health & Wellness產業。
Botanix Pharmaceuticals Limited 何時完成拆股?▼
Botanix Pharmaceuticals Limited 上次拆股發生於 June 16, 2016,比例為 1000:3333。
Botanix Pharmaceuticals Limited 的總部在哪裡?▼
Botanix Pharmaceuticals Limited 的總部位於 澳洲 的 West Perth。